I was just revisiting the Greenday Corporate website[one of the...

I was just revisiting the Greenday Corporate website[one of the new 2 substatial holders in SBN].I had convinced myself in the past that they would comlete a reverse takeover of SBN and that SBN shareholders would become shareholders in a new publicly listed company[refer AOS treatment].Then I noticed this on the company website:

As an investor we take equity positions in companies that demonstrate the following;
Significant growth potential
A clearly defined product or service and an identified market
Protected intellectual property
Competitive advantage
Management with ability to create value
Apart from the management issue which they will now provide is there hope for the drug testing products to be reinvented?Any thoughts.